GlassScriptPhysician profile
Catherine M Breen
NPI 1922179266
$3,240.06
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $513 · 2022: $991 · 2023: $1,735.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,645 · Education: $90.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,645.44 |
| Education | $90.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $565.77 | 2022-2023 | |
| Jazz Pharmaceuticals INC. | $431.05 | 2022-2023 | |
| Teva Pharmaceuticals USA, INC. | $337.91 | 2021-2023 | Austedo Xr, Ajovy |
| Pfizer INC. | $334.25 | 2021-2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $318.51 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $189.95 | 2021 | |
| Grt US Holding, INC. | $144.69 | 2022 | |
| Lundbeck LLC | $144.21 | 2023 | Vyepti |
| Idorsia Pharmaceuticals US INC | $135.75 | 2023 | Quviviq |
| Amgen INC. | $121.59 | 2021-2022 | |
| Impel Pharmaceuticals INC. | $87.83 | 2023 | Trudhesa |
| Lilly USA, LLC | $69.06 | 2022-2023 | Reyvow, Emgality |
| Redhill Biopharma INC. | $64.13 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $55.80 | 2021-2023 | Belbuca |
| Harmony Biosciences LLC | $35.89 | 2023 | Wakix |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $31.73 | 2023 | |
| Scilex Pharmaceuticals INC. | $28.70 | 2021-2022 | |
| Bioventus LLC | $24.47 | 2022 | |
| Nalu Medical, INC. | $22.49 | 2023 | Nalu Neurostimulation System |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.84 | 2022 | |
| Ibsa Pharma INC. | $19.54 | 2023 | Tirosint, Licart |
| Upsher-Smith Laboratories LLC | $19.45 | 2021 | |
| Horizon Therapeutics Plc | $19.38 | 2022 | |
| Eisai INC. | $17.07 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Breen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.